Tumor lysis syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
Nazia Fuad (talk | contribs) |
Nazia Fuad (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tumor lysis syndrome}} | {{Tumor lysis syndrome}} | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} {{N.F}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of tumor lysis syndrome after initiating [[chemotherapy]] is [[kidney disease]]. Other risk factors include [[dehydration]], hematologic tumors, and solid tumors. | The most potent risk factor in the development of tumor lysis syndrome after initiating [[chemotherapy]] is [[kidney disease]]. Other risk factors include [[dehydration]], hematologic tumors, and solid tumors. |
Revision as of 15:47, 27 August 2018
Tumor lysis syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tumor lysis syndrome risk factors On the Web |
American Roentgen Ray Society Images of Tumor lysis syndrome risk factors |
Risk calculators and risk factors for Tumor lysis syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Nazia Fuad M.D.
Overview
The most potent risk factor in the development of tumor lysis syndrome after initiating chemotherapy is kidney disease. Other risk factors include dehydration, hematologic tumors, and solid tumors.
Risk Factors
The followings are risk factors for developing tumor lysis syndrome after initiating chemotherapy:[1]
Common Risk Factors
- Common risk factors in the development of tumor lysis syndrome include:
Less Common Risk Factors
- Less common risk factors in the development of TLS include:
References
- ↑ "www.asn-online.org" (PDF).